Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities
Gang Li(The First People's Hospital of Shunde), Jianjun Chen(Southern Medical University), Yuxi Wang(Sichuan University), Xin Deng(State Key Laboratory of Respiratory Disease), Shuwen Liu(Zhengzhou University), Jin Liu(Southern Medical University), Ling Li(Donghua University), Meihua Luo(The First People's Hospital of Shunde), Wei Wang(Capital Medical University), Yichang Ren(Southern Medical University)
Cited by 53
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
|Science Immunology|2020|151